Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

BACKGROUND: Access to medicines in developing countries continues to be a significant problem due to lack of insurance and lack of affordability. Chronic Myeloid Leukemia (CML), a rare disease, can be treated effectively, but the pharmaceutical treatment available (imatinib) is costly and unaffordab...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanavos, Panos, Vandoros, Sotiris, Garcia-Gonzalez, Pat
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806257/
https://www.ncbi.nlm.nih.gov/pubmed/20043820
http://dx.doi.org/10.1186/1744-8603-5-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806257/
https://www.ncbi.nlm.nih.gov/pubmed/20043820
http://dx.doi.org/10.1186/1744-8603-5-19

Ejemplares similares